Bond Biosciences reported raising $5.34 Million in an initial SEC Form D filing, from an offering of $15 Million
Round Type
Venture
New YorkBiotechnologyHealth CareScience And EngineeringWho else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Bond Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Degron Therapeutics raised $40M (Series A) on May 14, 2026.
- Maze Therapeutics raised $145M (Post-IPO Equity) on April 22, 2026.
- Ray Therapeutics raised $125M (Series B) on April 21, 2026.
- Enveric Biosciences raised $5M on April 17, 2026.
- Orthogon Therapeutics raised $11M (Funding Round) on April 17, 2026.
- Athos Therapeutics, Inc. raised $10M on April 17, 2026.
Who to call at Bond Biosciences, and when
A new round usually means Bond Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Bond Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bond Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bond Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bond Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Bond Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.